Register entry

Patheon Italia S.p.A.

Data as of · How to read this entry

Registered sites
0
Active NDC listings
94
Labeller names
3
Live patents
0
Countries
0
Catalogue

Drug listings by form and route

94

94 active NDC listings: 92 drug for further processing, 1 bulk ingredient, 1 licensed vaccine bulk intermediate. By marketing category: DRUG FOR FURTHER PROCESSING 94.

Dosage formNDCs
injection, powder, lyophilized, for solution40
injection, solution21
powder, for solution12
injection7
solution4
powder3
injection, powder, for solution2
injection, solution, concentrate2
injection, suspension1
kit1
patch1
RouteNDCs
Labeller name on the listingNDCs
patheon italia s.p.a.78
patheon italia s.p.a13
patheon italia s.p.a3
Catalogue

Marketed products

94
BrandGeneric nameForm / routeNDC
-Abataceptinjection, powder, lyophilized, for solution68225-241DRUG FOR FURTHER PROCESSING
-Anakinrainjection, solution68225-067DRUG FOR FURTHER PROCESSING
-Basiliximabinjection, powder, for solution68225-237DRUG FOR FURTHER PROCESSING
-Basiliximabinjection, powder, for solution68225-238DRUG FOR FURTHER PROCESSING
-Cangrelorinjection, powder, lyophilized, for solution68225-062DRUG FOR FURTHER PROCESSING
-Coagulation factor ix (recombinant)injection, powder, lyophilized, for solution68225-242DRUG FOR FURTHER PROCESSING
-DEFIBROTIDE SODIUMinjection, solution68225-107DRUG FOR FURTHER PROCESSING
-DIFELIKEFALIN ACETATEinjection68225-122DRUG FOR FURTHER PROCESSING
-Daptomycininjection, powder, lyophilized, for solution68225-052DRUG FOR FURTHER PROCESSING
-Daptomycininjection, powder, lyophilized, for solution68225-082DRUG FOR FURTHER PROCESSING
-EFMOROCTOCOG ALFApowder, for solution68225-089DRUG FOR FURTHER PROCESSING
-EFMOROCTOCOG ALFApowder, for solution68225-090DRUG FOR FURTHER PROCESSING
-EFMOROCTOCOG ALFApowder, for solution68225-091DRUG FOR FURTHER PROCESSING
-EFMOROCTOCOG ALFApowder, for solution68225-092DRUG FOR FURTHER PROCESSING
-EFMOROCTOCOG ALFApowder, for solution68225-093DRUG FOR FURTHER PROCESSING
-EFMOROCTOCOG ALFApowder, for solution68225-094DRUG FOR FURTHER PROCESSING
-EFMOROCTOCOG ALFApowder, for solution68225-095DRUG FOR FURTHER PROCESSING
-EFMOROCTOCOG ALFApowder, for solution68225-096DRUG FOR FURTHER PROCESSING
-EFMOROCTOCOG ALFApowder, for solution68225-097DRUG FOR FURTHER PROCESSING
-EFMOROCTOCOG ALFApowder, for solution68225-098DRUG FOR FURTHER PROCESSING
-ERAVACYCLINE DIHYDROCHLORIDEinjection, powder, lyophilized, for solution68225-115DRUG FOR FURTHER PROCESSING
-EVOLOCUMABinjection, solution68225-080DRUG FOR FURTHER PROCESSING
-IOPAMIDOLinjection, solution68225-076DRUG FOR FURTHER PROCESSING
-IOPAMIDOLinjection, solution68225-077DRUG FOR FURTHER PROCESSING
-IOPAMIDOLinjection, solution68225-078DRUG FOR FURTHER PROCESSING
-IOPAMIDOLinjection, solution68225-100DRUG FOR FURTHER PROCESSING
-Indocyanine Green and Waterkit68225-069DRUG FOR FURTHER PROCESSING
-Infliximab, License Holder Unspecifiedinjection, powder, lyophilized, for solution68225-088DRUG FOR FURTHER PROCESSING
-LEFAMULIN ACETATEinjection, solution68225-105DRUG FOR FURTHER PROCESSING
-LUSPATERCEPTinjection, powder, lyophilized, for solution68225-118DRUG FOR FURTHER PROCESSING
-LUSPATERCEPTinjection, powder, lyophilized, for solution68225-119DRUG FOR FURTHER PROCESSING
-Nusinerseninjection, solution68225-085DRUG FOR FURTHER PROCESSING
-RISANKIZUMABinjection, solution68225-226DRUG FOR FURTHER PROCESSING
-RISANKIZUMABinjection, solution68225-227DRUG FOR FURTHER PROCESSING
-RISANKIZUMABinjection, solution68225-233DRUG FOR FURTHER PROCESSING
-ROMOSOZUMABinjection, solution68225-102DRUG FOR FURTHER PROCESSING
-Rezafungininjection, powder, lyophilized, for solution68225-236DRUG FOR FURTHER PROCESSING
-SOTATERCEPT-CSRKinjection, powder, lyophilized, for solution68225-243DRUG FOR FURTHER PROCESSING
-SOTATERCEPT-CSRKinjection, powder, lyophilized, for solution68225-244DRUG FOR FURTHER PROCESSING
-Thrombin, topical (Recombinant)powder, for solution68225-040DRUG FOR FURTHER PROCESSING
-Tigecyclineinjection, powder, lyophilized, for solution68225-013DRUG FOR FURTHER PROCESSING
-Vedolizumabinjection, powder, lyophilized, for solution68225-240DRUG FOR FURTHER PROCESSING
-apomorphine hydrochlorideinjection, solution68225-254DRUG FOR FURTHER PROCESSING
-asfotase alfasolution68225-274DRUG FOR FURTHER PROCESSING
-asfotase alfasolution68225-275DRUG FOR FURTHER PROCESSING
-asfotase alfasolution68225-276DRUG FOR FURTHER PROCESSING
-asfotase alfasolution68225-277DRUG FOR FURTHER PROCESSING
-bivalirudininjection, powder, lyophilized, for solution68225-041DRUG FOR FURTHER PROCESSING
-brodalumabinjection68225-086DRUG FOR FURTHER PROCESSING
-caplacizumabinjection, powder, lyophilized, for solution68225-256DRUG FOR FURTHER PROCESSING
-certolizumab pegolinjection, powder, lyophilized, for solution68225-045DRUG FOR FURTHER PROCESSING
-coagulation factor IX (recombinant)powder68225-059DRUG FOR FURTHER PROCESSING
-coagulation factor IX (recombinant)powder68225-060DRUG FOR FURTHER PROCESSING
-coagulation factor IX (recombinant)powder68225-061DRUG FOR FURTHER PROCESSING
-delafloxacin megluminepowder, for solution68225-099DRUG FOR FURTHER PROCESSING
-denosumab-bmwoinjection68225-271DRUG FOR FURTHER PROCESSING
-eculizumabinjection, solution, concentrate68225-042DRUG FOR FURTHER PROCESSING
-elotuzumabinjection, powder, lyophilized, for solution68225-245DRUG FOR FURTHER PROCESSING
-elotuzumabinjection, powder, lyophilized, for solution68225-246DRUG FOR FURTHER PROCESSING
-evolocumabinjection, solution68225-262DRUG FOR FURTHER PROCESSING
-fibrinogen human and human thrombinpatch68225-278DRUG FOR FURTHER PROCESSING
-hexaminolevulinate hydrochlorideinjection, powder, lyophilized, for solution68225-068DRUG FOR FURTHER PROCESSING
-imetelstat sodiuminjection, powder, lyophilized, for solution68225-248DRUG FOR FURTHER PROCESSING
-indocyanine greeninjection, powder, lyophilized, for solution68225-110DRUG FOR FURTHER PROCESSING
-infliximabinjection, powder, lyophilized, for solution68225-072DRUG FOR FURTHER PROCESSING
-lacosamideinjection68225-057DRUG FOR FURTHER PROCESSING
-lenacapavir sodiuminjection68225-234DRUG FOR FURTHER PROCESSING
-levetiracetaminjection, solution, concentrate68225-021DRUG FOR FURTHER PROCESSING
-mogamulizumab-kpkcinjection68225-258DRUG FOR FURTHER PROCESSING
-omadacyclineinjection, powder, lyophilized, for solution68225-111DRUG FOR FURTHER PROCESSING
-oritavancininjection, powder, lyophilized, for solution68225-051DRUG FOR FURTHER PROCESSING
-oritavancin diphosphateinjection, powder, lyophilized, for solution68225-121DRUG FOR FURTHER PROCESSING
-pneumococcal 15-valent conjugate vaccine crm197 protein adsorbedinjection, suspension68225-228DRUG FOR FURTHER PROCESSING
-ranibizumabinjection, solution68225-123DRUG FOR FURTHER PROCESSING
-remdesivirinjection, powder, lyophilized, for solution68225-117DRUG FOR FURTHER PROCESSING
-remimazolam besylateinjection, powder, lyophilized, for solution68225-120DRUG FOR FURTHER PROCESSING
-romiplostiminjection, powder, lyophilized, for solution68225-049DRUG FOR FURTHER PROCESSING
-romiplostiminjection, powder, lyophilized, for solution68225-050DRUG FOR FURTHER PROCESSING
-romiplostiminjection, powder, lyophilized, for solution68225-104DRUG FOR FURTHER PROCESSING
-rusfertideinjection, powder, lyophilized, for solution68225-266DRUG FOR FURTHER PROCESSING
-rusfertideinjection, powder, lyophilized, for solution68225-267DRUG FOR FURTHER PROCESSING
-rusfertideinjection, powder, lyophilized, for solution68225-268DRUG FOR FURTHER PROCESSING
-rusfertideinjection, powder, lyophilized, for solution68225-269DRUG FOR FURTHER PROCESSING
-rusfertideinjection, powder, lyophilized, for solution68225-270DRUG FOR FURTHER PROCESSING
-tedizolid phosphateinjection, powder, lyophilized, for solution68225-066DRUG FOR FURTHER PROCESSING
-teduglutideinjection68225-087DRUG FOR FURTHER PROCESSING
-teduglutideinjection, powder, lyophilized, for solution68225-265DRUG FOR FURTHER PROCESSING
-teprotumumabinjection, powder, lyophilized, for solution68225-264DRUG FOR FURTHER PROCESSING
-terlipressininjection, powder, lyophilized, for solution68225-257DRUG FOR FURTHER PROCESSING
-ustekinumab-stbainjection, solution68225-272DRUG FOR FURTHER PROCESSING
-ustekinumab-stbainjection, solution68225-273DRUG FOR FURTHER PROCESSING
-ustekinumab-ttweinjection, solution68225-250DRUG FOR FURTHER PROCESSING
-ustekinumab-ttweinjection, solution68225-251DRUG FOR FURTHER PROCESSING
-ustekinumab-ttweinjection, solution68225-253DRUG FOR FURTHER PROCESSING
Compare

Other companies listing efmoroctocog alfa

Enquiry

Common questions

Is Patheon Italia S.p.A. FDA approved?
Patheon Italia S.p.A. holds no registered establishment of its own; 94 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
What drugs does Patheon Italia S.p.A. make?
94 products are listed under Patheon Italia S.p.A. in the openFDA NDC Directory, most often as injection, powder, lyophilized, for solution; injection, solution; powder, for solution. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.